Advanced Micro Devices, Inc. (NYSE:AMD)’s shares declined 1.48% to $4. The company will webcast its quarterly earnings conference call on Thursday, April 17, 2014 at 5:30 p.m. EDT / 2:30 p.m. PDT to discuss the results of its fiscal first quarter ending March 29, 2014. Advanced Micro Devices, Inc. (NYSE:AMD) shares after opening at $4.03 moved to $4.11 on last trade day and at the end of the day closed at $4.01. Company price to sales ratio in past twelve months was calculated as 0.58 and price to cash ratio as 2.78. Advanced Micro Devices, Inc. (NYSE:AMD) showed a positive weekly performance of 3.35%.
Merck & Co. (NYSE:MRK) Insider Bruce N. Kuhlik sold 145,225 shares of the stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $56.43, for a total value of $8,195,046.75. Merck & Co., Inc. (NYSE:MRK) shares fell -0.16% in last trading session and ended the day on $56.12. MRK return on equity ratio is recorded as 12.10% and its return on assets is 5.60%. Merck & Co., Inc. (NYSE:MRK) yearly performance is 31.77%.
Adobe Systems (NASDAQ:ADBE) Chairman Charles Geschke sold 33,500 shares of Adobe Systems stock on the open market in a transaction that occurred on Tuesday, April 1st. Adobe Systems Incorporated (NASDAQ:ADBE) shares moved down -1.81% in last trading session and was closed at $61.32 while trading in range of $61.10 – $62.92 – Adobe Systems Incorporated (NASDAQ:ADBE) year to date (YTD) performance is 2.40%.
Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or the “Company”), an emerging leader in DNA-based cancer diagnostics, has launched a genetic diagnostic test for detecting mutations in the calreticulin (CALR) gene. This test helps physicians identify patients with certain types of myeloproliferative neoplasms (MPN), which are blood cancers that have the potential to evolve into acute leukemia. Cancer Genetics Inc (NASDAQ:CGIX) shares moved up 1.2% in last trading session and was closed at $15.92 while trading in range of $15.80 – $16.80.
Leave a Reply